Drugs / GoFast CD19 CAR T cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT07670260 | Jun 2026 → Sep 2027 expected | large B-cell lymphoma | Chinese PLA General Hospital | Not yet recruiting | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GoFast CD19 CAR T cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07670260 ↗ |
| Modality | Cell therapy | “chimeric antigen receptor T cells” NCT07670260 ↗ |
| Route | Intravenous | “followed by intravenous infusion of GoFast CD19 CAR T cells” NCT07670260 ↗ |
| Target | CD19 | “CD19-targeted” NCT07670260 ↗ |